TY - JOUR T1 - Abstract B109: MTHFD1/2 inhibitor TH9619 targets the DNA damage response and causes cancer-specific folate trapping with an unprecedented therapeutic window JO - Molecular Cancer Therapeutics UR - http://dx.doi.org/10.1158/1535-7163.targ-23-b109 PY - 2023/12/01 AU - Martilla P AU - Green AC AU - Kiweler N AU - Chalkiadaki C AU - Wiita E AU - Cookson V AU - Lesur A AU - Eiden K AU - Bernhardin F AU - Long M AU - Jemth A-S et al ED - DO - DOI: 10.1158/1535-7163.targ-23-b109 PB - American Association for Cancer Research (AACR) VL - 22 IS - 12_Supplement SP - B109 EP - B109 Y2 - 2025/04/09 ER -